Cytek Muse Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek Muse Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual program, conducted by leading independent market intelligence organization BioTech Breakthrough, recognizes innovative life sciences and biotechnology companies, products, and services worldwide. This year’s competition drew thousands of nominations from more than 15 countries.

The award highlights Cytek’s commitment to making cell analysis more accessible, intuitive, and cost-effective for laboratories of all sizes. The Muse Micro cell analyzer builds on the legacy of the original Guava Muse system, which revolutionized flow cytometry for thousands of laboratories. The enhanced Muse Micro system expands upon this proven success with extended capabilities to create an affordable, multifunctional system with a compact footprint that simplifies flow cytometry while delivering ease of use, accuracy, and versatility. Applications include cell counting, cell health and viability, apoptosis, immunophenotyping, immune cell monitoring, fluorescent protein analysis, and more.

“With the Cytek Muse Micro cell analyzer, sophisticated cell analysis is no longer exclusive, complex, or expensive,” said Bryan Vaughn, managing director, BioTech Breakthrough. “Traditional flow cytometry systems are often all these things, restricting use to well-funded labs with extensive experience. Smaller labs, emerging markets, and resource-limited facilities find high-quality cell analysis to be inaccessible. The Muse Micro system combines affordability, compact design, and intuitive operation with advanced analytical capabilities, thereby lowering the financial and technical barriers to flow cytometry. For this important breakthrough, we’re awarding Cytek with the ‘Drug Discovery Solution of the Year’.”

The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the world’s top companies, solutions and products in the life sciences and biotechnology markets today.

“The Cytek Muse Micro cell analyzer furthers our mission of making high-quality flow cytometry more accessible,” said Wenbin Jiang, Ph.D., CEO of Cytek Biosciences. “In fact, the Muse Micro system is already demonstrating how a compact, cost-effective, and easy-to-use platform can simplify workflows and help laboratories of all sizes advance their research with greater efficiency and confidence.”